Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Orphan Drug
.
Show all posts
Showing posts with label
Orphan Drug
.
Show all posts
Thursday, June 11, 2026
Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes
›
Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes of inflammation-driven...
Saturday, March 16, 2019
FDA Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
›
Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, announced that the U.S. Food and Dr...
Tuesday, September 4, 2012
‘Orphan drug’ used to treat sleep disorders may be a potent cancer-fighting agent used for many malignancies, study finds
›
An inexpensive "orphan drug" used to treat sleep disorders appears to be a potent inhibitor of cancer cells, according to a new ...
›
Home
View web version
